Kamada (KMDA) Other Working Capital Changes (2014 - 2026)
Kamada's (KMDA) quarterly Other Working Capital Changes came in at -$389000.0 in Q1 2026, down 2678.57% YoY from $15085.9 in Q1 2025, and down 179.86% on a QoQ basis from -$139000.0 in Q4 2025.
Kamada (KMDA) Other Working Capital Changes (2014 - 2026) Analysis & Trends
Kamada (KMDA) has 15 years of Other Working Capital Changes data on file, last reported at -$389000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 2678.57% year-over-year to -$389000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.3 million (down 31.93% YoY) and the FY2025 annual result came in at -$972000.0, up 22.3% from the prior year.
- Other Working Capital Changes slipped to -$389000.0 in Q1 2026, from -$139000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $845000.0 in Q3 2025 to a low of -$1.0 million in Q4 2025.
- A 4-year average of -$27047.4 and a median of $1000.0 in 2024 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 99.91% in 2023, down 93208.55% in 2023.
- Tracing KMDA's Other Working Capital Changes over 5 years: stood at -$256000.0 in 2022, then surged by 67.97% to -$82000.0 in 2023, then tumbled by 340.24% to -$361000.0 in 2024, then jumped by 61.5% to -$139000.0 in 2025, then tumbled by 179.86% to -$389000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$389000.0 (Q1 2026), -$139000.0 (Q4 2025), and -$415000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Kamada | 462.32 Mn | 432.85 Mn | 22.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67,000.00 |
| Mar 31, 2026 | 67,000.00 |
| Mar 31, 2026 | 67,000.00 |
| Dec 31, 2025 | -1.02 Mn |
| Dec 31, 2025 | -1.02 Mn |
| Dec 31, 2025 | -1.02 Mn |
| Sep 30, 2025 | 845,000.00 |
| Sep 30, 2025 | 845,000.00 |
| Sep 30, 2025 | 845,000.00 |
| Jun 30, 2025 | -28,000.00 |
| Jun 30, 2025 | -28,000.00 |
| Jun 30, 2025 | -28,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Dec 31, 2024 | 130,000.00 |
| Dec 31, 2024 | 130,000.00 |
| Dec 31, 2024 | 130,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Sep 30, 2024 | 14,000.00 |